April 2025 update on U.S. pharmaceutical regulation highlights executive orders, budget changes, CMS policies, IRA litigation, and 340B program developments shaping drug pricing and access.
The Health Tech Investment Act aims to create a consistent Medicare payment system for FDA-approved AI medical devices, enhancing patient access and improving healthcare outcomes.
Dr. Mehmet Oz confirmed as CMS leader, emphasizing Medicare and Medicaid modernization, targeting fraud, and navigating potential Medicaid funding challenges amid federal budget pressures.
Maine advocates seek Medicare coverage for anti-obesity medications to improve public health, reduce healthcare costs, and promote active transportation. Bipartisan support grows with Senator Susan Collins' leadership.
Explore how automated bill payments are increasingly embraced by older adults to ensure timely insurance premium payments and reduce financial risk. Learn expert insights on secure digital payment practices and compliance in eldercare finance.
Comprehensive overview of Washington State's 2024 health insurance plans, benefits, enrollment periods, small business options, and regulatory compliance for insurance professionals.
Medicare Advantage enrollment growth slows in 2025 with for-profit plans covering three-quarters of beneficiaries. Quality ratings decline and workforce shortages drive interest in advanced practice providers and AI solutions.
CMS finalizes key elements of the CY 2026 Medicare Advantage and Medicare Part D final rule, including insulin coverage expansion, Prescription Payment Plan codification, pharmacy data requirements, and updated enrollee protections.
CMS drives healthcare efficiency with initiatives like the HL7 FHIR Connectathon, Oklahoma directory pilot, HIPAA updates, and new prior authorization rules for Medicare and Medicaid.
Summary of Trump's executive order directing HHS to reduce prescription drug costs, focusing on Medicare reimbursement for 340B drugs, IRA drug pricing provisions, and CMS premium stabilization efforts.
